Ghost Tree Capital, LLC - Q3 2021 holdings

$342 Million is the total value of Ghost Tree Capital, LLC's 60 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 100.0% .

 Value Shares↓ Weighting
PRVB ExitPROVENTION BIO INCput$0-150,000
-100.0%
-0.35%
ELEV ExitELEVATION ONCOLOGY INC$0-100,000
-100.0%
-0.37%
CERE ExitCEREVEL THERAPEUTICS HLDNG I$0-75,000
-100.0%
-0.53%
CRIS ExitCURIS INC$0-247,124
-100.0%
-0.55%
KDMN ExitKADMON HLDGS INC$0-800,000
-100.0%
-0.85%
GLPG ExitGALAPAGOS NVspon adr$0-75,000
-100.0%
-1.42%
EPIX ExitESSA PHARMA INC$0-207,500
-100.0%
-1.63%
MRSN ExitMERSANA THERAPEUTICS INC$0-450,000
-100.0%
-1.68%
TGTX ExitTG THERAPEUTICS INC$0-180,000
-100.0%
-1.92%
BIIB ExitBIOGEN INC$0-32,500
-100.0%
-3.09%
ExitTRILLIUM THERAPEUTICS INC$0-1,250,000
-100.0%
-3.33%
XBI ExitSPDR SER TRcall$0-300,000
-100.0%
-11.17%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MIRATI THERAPEUTICS INC30Q3 20237.3%
ASCENDIS PHARMA A/S - ADR28Q3 202311.8%
BIOCRYST PHARMACEUTICALS INC25Q2 20232.4%
AMICUS THERAPEUTICS INC23Q3 20235.6%
SAREPTA THERAPEUTICS INC22Q3 20239.1%
SPDR SER TR20Q3 202216.9%
IOVANCE BIOTHERAPEUTICS INC18Q2 20235.5%
ROCKET PHARMACEUTICALS INC18Q2 20236.1%
SAGE THERAPEUTICS INC18Q1 20214.8%
IMMUNOMEDICS INC17Q2 20208.7%

View Ghost Tree Capital, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-16
13F-HR2021-11-15

View Ghost Tree Capital, LLC's complete filings history.

Compare quarters

Export Ghost Tree Capital, LLC's holdings